Aequus Pharmaceuticals Inc (AQS) — Working Capital to Net Assets Ratio
Aequus Pharmaceuticals Inc (AQS) has a Working Capital to Net Assets ratio of 100.0% as of September 2025. Working capital of CA$-6.89 Million (current assets of CA$196.16K minus current liabilities of CA$7.09 Million) is measured against net assets of CA$-6.89 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See AQS FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Aequus Pharmaceuticals Inc Working Capital to Net Assets (2013–2024)
This chart shows how Aequus Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2013 to 2024. As of September 2025, the ratio stands at 100.0%, reflecting working capital of CA$-6.89 Million against net assets of CA$-6.89 Million CAD. See Aequus Pharmaceuticals Inc (AQS) liquidity interval to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Aequus Pharmaceuticals Inc (2013–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Aequus Pharmaceuticals Inc from 2013 to 2024, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Aequus Pharmaceuticals Inc (AQS) market capitalisation.
| Year | WC/NA Ratio | Working Capital (CAD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 100.9% | CA$-6.51 Million | CA$-6.45 Million | CA$282.00K | CA$6.80 Million | ▼ -0.6 pp |
| 2023 | 101.6% | CA$-4.36 Million | CA$-4.29 Million | CA$435.61K | CA$4.80 Million | ▼ -5.3 pp |
| 2022 | 106.9% | CA$-1.48 Million | CA$-1.38 Million | CA$902.69K | CA$2.38 Million | ▲ +43.4 pp |
| 2021 | 63.5% | CA$1.14 Million | CA$1.79 Million | CA$3.59 Million | CA$2.46 Million | ▼ -351.9 pp |
| 2020 | 415.4% | CA$2.38 Million | CA$573.95K | CA$2.77 Million | CA$384.32K | ▲ +487.4 pp |
| 2019 | -72.0% | CA$631.69K | CA$-877.09K | CA$1.11 Million | CA$476.05K | ▼ -126.7 pp |
| 2018 | 54.7% | CA$920.17K | CA$1.68 Million | CA$1.24 Million | CA$314.90K | ▼ -3.8 pp |
| 2017 | 58.5% | CA$1.35 Million | CA$2.31 Million | CA$1.71 Million | CA$366.84K | ▲ +53.8 pp |
| 2016 | 4.7% | CA$59.14K | CA$1.27 Million | CA$803.55K | CA$744.41K | ▼ -14.0 pp |
| 2015 | 18.7% | CA$239.86K | CA$1.28 Million | CA$1.38 Million | CA$1.15 Million | ▼ -81.1 pp |
| 2014 | 99.8% | CA$2.92 Million | CA$2.92 Million | CA$3.66 Million | CA$744.51K | ▲ +2.2 pp |
| 2013 | 97.6% | CA$273.85K | CA$280.60K | CA$330.59K | CA$56.74K | — |